PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Respiratory Medicine, Sir Run Run Hospital, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.\', \'Department of Respiratory Medicine, the Second Clinical Medical School of Nanjing Medical University, Nanjing, 210011, Jiangsu, China.\', \'Department of Critical Care Medicine, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, Jiangsu, China.\', \'Department of Respiratory Medicine, Huangshi Central Hospital, Hangshi, 435000, Hubei, China.\', \'Department of Nephrology, Huangshi Hospital of Traditional Chinese Medicine, Hangshi, 435000, Hubei, China.\', \'Jiangsu Cell Tech Medical Research Institute, Nanjing, 211166, Jiangsu, China.\', \'Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.\', \'Department of Pulmonary and Critical Care Medicine, the Second Affiliated Hospital of Nanjing Medical University, Address: No. 121 Jiangjiayuan Rd, Gulou District, Nanjing, 210011, Jiangsu, China. fenggz163@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13287-020-01875-5
?:hasPublicationType
?:journal
  • Stem cell research & therapy
is ?:pmid of
?:pmid
?:pmid
  • 32811531
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all